Ligand validation:8BU6

RQE: ~{N}-(1~{H}-benzimidazol-2-ylmethyl)-9-(1-methylpyrazol-4-yl)-2-morpholin-4-yl-purin-6-amine

RQE is a Ligand Of Interest in 8BU6 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8BU6_RQE_B_1101	12%	47%	0.38	0.919	0.94	1.1	1	3	0	0	100%	1
8BU6_RQE_H_1101	10%	47%	0.406	0.909	1.04	1	2	2	0	0	100%	1
8BU6_RQE_E_1101	9%	49%	0.413	0.903	0.97	1	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.